Gene: TBC1D32
Official Full Name: TBC1 domain family member 32provided by HGNC
Gene Summary: This gene encodes a TBC-domain containing protein. Studies of a similar protein in mouse and zebrafish suggest that the encoded protein is involved in sonic hedgehog signaling, and that it interacts with and stabilizes cell cycle-related kinase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27516 | TBC1D32 Knockout cell line (HeLa) | Human | TBC1D32 | 1:3~1:6 | Negative | Online Inquiry |
KO27517 | TBC1D32 Knockout cell line (HCT 116) | Human | TBC1D32 | 1:2~1:4 | Negative | Online Inquiry |
KO27518 | TBC1D32 Knockout cell line (HEK293) | Human | TBC1D32 | 1:3~1:6 | Negative | Online Inquiry |
KO27519 | TBC1D32 Knockout cell line (A549) | Human | TBC1D32 | 1:3~1:4 | Negative | Online Inquiry |
TBC1D32 Gene Knockout Cell Lines are precisely engineered cell lines designed to disrupt the TBC1D32 gene, which encodes a protein implicated in the regulation of intracellular trafficking and signaling pathways. These knockout cell lines serve as essential tools for researchers investigating the functional roles of TBC1D32 in various biological processes and disease models. By eliminating the expression of this gene, scientists can gain valuable insights into how TBC1D32 influences cellular functions such as metabolism, cell growth, and response to stressors.
The key mechanism of action of these knockout cell lines involves the CRISPR-Cas9 gene-editing technology, which enables specific and efficient alteration of the TBC1D32 locus. This allows researchers to observe phenotypic changes and elucidate the biological pathways influenced by TBC1D32 disruption. The implications of these investigations are profound, as understanding such pathways can contribute to uncovering the molecular underpinnings of disorders, including cancer and metabolic diseases, where TBC1D32 may play a role.
Compared to traditional gene silencing methods, such as siRNA or shRNA, TBC1D32 Gene Knockout Cell Lines offer a more stable and permanent solution, ensuring sustained disruption of gene expression for long-term studies. Furthermore, these cell lines come validated for authenticity and biological relevance, minimizing variability and enhancing reproducibility in experimental outcomes.
This product is invaluable for researchers and clinicians aiming to delve deeper into gene function and associated pathological mechanisms. With the ability to model specific genetic conditions, the TBC1D32 Gene Knockout Cell Lines are essential for advancing drug discovery and therapeutic development initiatives.
Our company brings unparalleled expertise in developing high-quality genetic models, ensuring that our products meet rigorous scientific standards. By choosing our TBC1D32 Gene Knockout Cell Lines, you are equipping yourself with a vital resource for your research, backed by a commitment to innovation and excellence in the biological research field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.